These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6755279)

  • 1. Transplantation antigens on renal endothelium.
    Paul LC; Baldwin WM; Van Es LA
    Neth J Med; 1982; 25(7):208-14. PubMed ID: 6755279
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kinetics of serum soluble HLA-A, B and DR antigens on human renal allografts].
    Shiramizu T
    Fukuoka Igaku Zasshi; 1983 Dec; 74(12):787-95. PubMed ID: 6373538
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-HLA-A, B, C and DR antibodies in renal transplant recipients.
    Akiyama N; Kusaba R; Osawa N; Inou T; Kawamura A
    Jpn J Exp Med; 1980 Jun; 50(3):205-11. PubMed ID: 7001096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial cell expression of adhesion molecules and HLA antigens in renal allografts.
    Faull RJ; Starr RJ; Russ GR
    Transplant Proc; 1989 Feb; 21(1 Pt 1):316-7. PubMed ID: 2650131
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperacute rejection from antibody against class II HLA antigens.
    Ghasemian SR; Light JA; Sasaki TA; Barhyte DY
    Clin Transplant; 1998 Dec; 12(6):569-71. PubMed ID: 9850452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immunity in renal transplantation Detection of cytotoxic antibodies to lymphocyte antigens other than HLA-A,B,C and Ia-like antigens in patients with vascular graft rejection.
    Lordon RE; Wilson RL; Shield CF; Ferrone S
    Transplantation; 1981 Oct; 32(4):286-90. PubMed ID: 7036445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histocompatibility testing in clinical renal transplantation.
    Braun WE
    Urol Clin North Am; 1983 May; 10(2):231-42. PubMed ID: 6222529
    [No Abstract]   [Full Text] [Related]  

  • 8. Antigenic composition of human renal vascular endothelium assessed by kidney perfusion.
    Baldwin WM; Claas FH; van Rood JJ; van Es LA
    Tissue Antigens; 1984 May; 23(5):256-62. PubMed ID: 6379984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of HLA-DR, -DQ, and -DP antigens on renal tubular cells during rejection episodes.
    Russ GR; Pascoe V; d'Apice AJ; Seymour AE
    Transplant Proc; 1986 Apr; 18(2):293-7. PubMed ID: 3515666
    [No Abstract]   [Full Text] [Related]  

  • 10. The importance of tissue typing in cadaveric kidney transplantation (pros).
    Sirchia G
    Contrib Nephrol; 1982; (34):101-10. PubMed ID: 6756776
    [No Abstract]   [Full Text] [Related]  

  • 11. Histocompatibility. Influence of HLA-DR matching on renal graft survival. A Scandiatransplant report.
    Moen T; Berger L; Goyer K; Dahl O; Thorsby E
    Scand J Urol Nephrol Suppl; 1981; 64():30-7. PubMed ID: 6815792
    [No Abstract]   [Full Text] [Related]  

  • 12. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
    Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW
    Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of major histocompatibility complex (MHC) class II antigens and HLA-DR incompatibility.
    Oba S; Toma H; Takahashi K; Ota K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):323-4. PubMed ID: 2650137
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation of HLA class II antigen induction and cellular infiltration in renal allograft rejection.
    McWhinnie DL; Fuggle SV; Azevedo LS; Carter NP; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):320-1. PubMed ID: 2650134
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence that antibodies eluted from rejected kidneys of HLA-identical transplants define a non-MHC alloantigen expressed on human kidneys.
    Mathew JM; Joyce S; Lawrence W; Mohanakumar T
    Transplantation; 1991 Sep; 52(3):559-62. PubMed ID: 1897033
    [No Abstract]   [Full Text] [Related]  

  • 16. HLA-DR matching: the impact on cadaveric renal transplantation. A single-center study.
    Madsen M; Graugaard B; Fjeldborg O; Posborg V; Hansen HE; Lamm LU; Kissmeyer-Nielsen F
    Scand J Urol Nephrol Suppl; 1981; 64():56-63. PubMed ID: 6815794
    [No Abstract]   [Full Text] [Related]  

  • 17. An analysis of the cell specificity of the antibody response accompanying human renal allograft rejection.
    Cerilli J; Holliday JE; Koolemans-Beynen A
    Surgery; 1978 Jun; 83(6):726-31. PubMed ID: 347618
    [No Abstract]   [Full Text] [Related]  

  • 18. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
    Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report.
    Süsal C; Döhler B; Opelz G
    Hum Immunol; 2009 Aug; 70(8):569-73. PubMed ID: 19375472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.